Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VYGRthis companyVoyager Therapeutics, Inc.	$2.03	-1.93×	1.18×	5.71×	-1.75×	-324.0%	-227.6%	-326.6%	-296.5%	-61.1%	-56.4%	-58.6%	0.19×	0.25×	0×	7.64×	0.0%	2	-3.18	2	C
ACHVAchieve Life Sciences, Inc.	$6.82	-3.98×	10.07×	0×	-3.93×	-98.2%	0.0%	0.0%	0.0%	-254.0%	-150.5%	-22.8%	0.69×	0.11×	-67.01×	4.39×	0.0%	2	-2.53	2	C
ALLOAllogene Therapeutics, Inc.	$1.06	-1.57×	1.03×	0×	-1.88×	-114.9%	0.0%	0.0%	0.0%	-65.3%	-52.8%	-49.5%	0.28×	-0.18×	-192.5×	7.93×	0.0%	2	-4.59	2	C
ARCTArcturus Therapeutics Holdings Inc.	$9.87	-2.55×	0.78×	2.5×	0.61×	-135.5%	95.5%	-111.5%	-97.9%	-30.7%	-31.4%	-44.2%	0.12×	3.28×	0×	6.64×	0.0%	1	-0.16	2	C
AVIRAtea Pharmaceuticals, Inc.	$4.47	-1.84×	1.06×	0×	-1.19×	-77.0%	0.0%	0.0%	0.0%	-57.5%	-63.0%	-45.4%	0×	0.58×	0×	7.82×	0.0%	1	6.93	3	B-
ENTAEnanta Pharmaceuticals, Inc.	$11.57	-3.12×	3.95×	3.91×	-5.99×	-611.3%	93.0%	-130.7%	-125.4%	-126.5%	-31.4%	-12.6%	3.11×	-2.38×	-11.11×	4.21×	0.0%	3	-0.87	1	C-
Peer median	—	-2.55×	1.06×	0×	-1.88×	-114.9%	0.0%	0.0%	0.0%	-65.3%	-52.8%	-44.2%	0.28×	0.11×	-11.11×	6.64×	0.0%	2	-0.87	2	—